相关实验视频

Updated: May 31, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

向EPHB2/ABL1恢复了前临床模型上尾瘤的抗瘤免疫力

Jun Ren¹, Zohreh Amoozgar¹, Taylor P Uccello¹

¹Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.

Proceedings of the National Academy of Sciences of the United States of America

|January 22, 2025

概括

达沙替尼有效地通过向ZFTA-RELA融合来治疗儿科 supratentorial端膜瘤 (ST-EPN). 这种药物抑制瘤生长,重编程免疫微环境,并诱导大多数小鼠的瘤完全回归,提供了一个有前途的新疗法.

科学领域:

儿科瘤学儿科瘤学
神经瘤学神经瘤学
癌症免疫学癌症免疫学

背景情况:

膜瘤 (EPN) 是一种常见的儿科脑瘤,通常对化疗有抗性.
分子亚型,如ZFTA-RELA融合的 supratentorial ependymoma (ST-EPN),已被识别,但免疫系统的作用尚不清楚.
对于各种EPN分子亚型,迫切需要新的治疗策略.

研究的目的:

为了研究ST-EPN-ZFTA中的免疫微环境.
为了确定ST-EPN-ZFTA的可使用药物的目标.
在ST-EPN-ZFTA模型中评估达沙替尼的疗效.

主要方法:

使用了特定于ST-EPN-ZFTA亚型的同源性小鼠模型.
进行了瘤的转录基因分析,并分析了人类EPN数据集.
评估达沙替尼的体外和体内疗效,包括免疫细胞调节和存活.

主要成果:

与瘤进展相关的M2型瘤相关巨细胞 (TAMs) 的增加.
达沙替尼通过向EPHB2和ABL1来抑制EPN生长,将TAM重编程为M1-类表型,并增强CD8T细胞激活.
达沙替尼在78%的动物中诱导了完全的回归,持久的反应取决于CD8 T细胞.

结论:

达沙替尼 (Dasatinib) 显示出作为ST-EPN-ZFTA分子子组治疗的显著潜力.
重新编程瘤免疫微环境和增强T细胞反应是达沙替尼的有效性的关键机制.
对于ST-EPN,需要对达沙替尼进行进一步的临床研究.

关键词:

没有能力,没有能力.在 Ephb2 中,这就是ZFTA-RELA.在此之前,我们已经研究了Ependymomaoma和Ependymoma.瘤免疫微环境是一个微环境.

更多相关视频

Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development

Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development

Published on: September 4, 2021

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...